Whitepaper: The Medical Literature Review and Monitoring of the EMA

From 1st July 2015, the European Medicines Agency (EMA) became responsible for monitoring medical literature to identify any suspected adverse reactions with medicines authorised in the European Union (EU) [11].

DOWNLOAD NOW

**For more information, please see Cencora PharmaLex Privacy Policy. If you do not wish to receive any communication from us, you may unsubscribe at any time.

The review of medical literature and searching of relevant databases is an important factor in identifying any individual case safety reports (ICSRs) and safety study reports relating to:

  • Suspected adverse reactions to a medicine
  • Special situations such use during pregnancy or off-label use
  • Lack of therapeutic efficacy
  • Identification of falsified medicinal products and any resulting adverse events (AE)
  • Suspected transmission of an infectious agent via a medicinal product [11].
Download The free eBook